Conference Coverage

Delayed-release metformin proves promising for diabetic renal disease

Publish date: September 27, 2017

 

AT EASD 2017

Pages

Recommended Reading

Most type 2 diabetes patients skipping metformin as first-line therapy
MDedge Endocrinology
Diabetes infusion sets under voluntary recall
MDedge Endocrinology
AWARD-7: Dulaglutide benefits patients with diabetic renal disease
MDedge Endocrinology
Obtaining cystatin-C levels useful in chronic kidney disease
MDedge Endocrinology
No increased overall cardiovascular risk seen with exenatide use
MDedge Endocrinology
Alirocumab’s ODYSSEY continues: Efficacy unaffected by insulin, beats fenofibrate
MDedge Endocrinology
CONCEPTT: Continuous glucose monitoring during pregnancy benefits baby
MDedge Endocrinology
Wound expert: Consider hyperbaric oxygen therapy for diabetic foot ulcers
MDedge Endocrinology
Roux-en-Y gastric bypass produced durable clinical improvements at 12 years
MDedge Endocrinology
Empagliflozin’s effects independent of CVD risk factors
MDedge Endocrinology